SOAT1
SOAT1, also known as ACAT, ACAT1, SOAT or STAT, is an endoplasmic reticulum membrane enzyme that catalyses the formation of fatty acid-cholesterol esters. It links free cholesterol handling to lipoprotein assembly and dietary cholesterol absorption. Browse Assay Genie's current range of SOAT1 research reagents below, or read on for the biology behind the target.
SOAT1 (sterol O-acyltransferase 1) catalyses the formation of fatty acid-cholesterol esters, which are less soluble in membranes than free cholesterol. By converting cholesterol into these esters, the enzyme controls the equilibrium between free cholesterol and cytoplasmic cholesteryl esters. It also plays a role in lipoprotein assembly and dietary cholesterol absorption. SOAT1 preferentially uses oleoyl-CoA as a substrate, showing higher activity towards an acyl-CoA with a double bond at the delta-9 (9Z) position than towards saturated acyl-CoA or unsaturated acyl-CoA with a double bond at the delta-7 (7Z) or delta-11 (11Z) positions.
The SOAT1 protein is located in the endoplasmic reticulum membrane. It belongs to the membrane-bound O-acyltransferase family and, within it, the sterol O-acyltransferase subfamily. The human SOAT1 gene encodes this enzyme, and alternatively spliced transcript variants have been reported. Mouse and rat both carry an orthologous Soat1 gene.
The gene has previously been named sterol O-acyltransferase (acyl-Coenzyme A: cholesterol acyltransferase) 1, which explains the aliases ACAT and ACAT1 that still appear in the literature. Its control of free cholesterol and cholesteryl ester balance has led to its implication in the formation of beta-amyloid and atherosclerotic plaques, making it a subject of interest in both neurodegeneration and cardiovascular research.
SOAT1 catalyses fatty acid-cholesterol ester formation, making it central to work on how cells balance free cholesterol and cholesteryl esters.
The gene has been implicated in atherosclerotic plaque formation through its control of free versus esterified cholesterol.
SOAT1 has been implicated in beta-amyloid formation, linking cholesterol ester metabolism to amyloid-related research.
The enzyme contributes to lipoprotein assembly and dietary cholesterol absorption, relevant to studies of lipid handling.
SOAT1 catalyses the formation of fatty acid-cholesterol esters, which are less soluble in membranes than cholesterol. It contributes to lipoprotein assembly and dietary cholesterol absorption, and prefers oleoyl-CoA as an acyl donor. It acts in the endoplasmic reticulum membrane.
The earlier gene name was sterol O-acyltransferase (acyl-Coenzyme A: cholesterol acyltransferase) 1, so ACAT and ACAT1 are legacy symbols. Other aliases include SOAT and STAT. Alternatively spliced transcript variants have been described for this gene.
SOAT1 has been implicated in beta-amyloid and atherosclerotic plaque formation through its control of free cholesterol and cholesteryl esters. Mouse and rat both have an orthologue named Soat1; check the datasheet of any product for its validated reactivity.
Other cholesterol-metabolism enzymes, lipoprotein-related proteins and amyloid pathway markers with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P35610; product specifications from Assay Genie datasheets.